Dynamic models of immune responses: what is the ideal level of detail? by Thakar, Juilee et al.
COMMENTARY Open Access
Dynamic models of immune responses: what is
the ideal level of detail?
Juilee Thakar
1*, Mary Poss
2, Réka Albert
1, Gráinne H Long
1, Ranran Zhang
2
* Correspondence:
jthakar@phys.psu.edu
1Center for Infectious Disease
Dynamics and Department of
Physics, Pennsylvania State
University, University Park, PA
16802, USA
Abstract
Background: One of the goals of computational immunology is to facilitate the
study of infectious diseases. Dynamic modeling is a powerful tool to integrate
empirical data from independent sources, make novel predictions, and to foresee the
gaps in the current knowledge. Dynamic models constructed to study the
interactions between pathogens and hosts’ immune responses have revealed key
regulatory processes in the infection.
Optimum complexity and dynamic modeling: We discuss the usability of various
deterministic dynamic modeling approaches to study the progression of infectious
diseases. The complexity of these models is dependent on the number of
components and the temporal resolution in the model. We comment on the specific
use of simple and complex models in the study of the progression of infectious
diseases.
Conclusions: Models of sub-systems or simplified immune response can be used to
hypothesize phenomena of host-pathogen interactions and to estimate rates and
parameters. Nevertheless, to study the pathogenesis of an infection we need to
develop models describing the dynamics of the immune components involved in
the progression of the disease. Incorporation of the large number and variety of
immune processes involved in pathogenesis requires tradeoffs in modeling.
Background
Immune responses encompass a large range of temporal- (millisecond to days) and
spatial (molecular to whole body) scales. It is increasingly recognized that intuitive
arguments are not sufficient to make sense of this complexity. As an alternative,
dynamic models are more and more frequently used to synthesize and complement
empirical studies. Many dynamic models lead to valuable insights and predictions. For
example, early dynamic models of infections provide a significant insight into the pro-
gression of AIDS [1,2].
The specific goal of a dynamic model of an infection may be to estimate certain
parameters [3], to test competing hypotheses that can explain a set of observations
[4,5] or to study the interplay between a pathogen and a host which can result in a
progressive infection [6,7]. Immunological models consist of components representing
immunological entities such as cells and cytokines, equations representing how the
relationship between components changes their status, and parameters (e.g. rate con-
s t a n t s )p l u g g e di n t ot h ee q u a t i o n sw h i c hdefine the strength and timing of the
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any medium, provided the original work is properly cited.relationships. Among the various mathematical frameworks employed by dynamic
models (see Table 1), the deterministic (noise-free) framework is most frequently used
at the cellular level. As the number of components included in a model increases, so
does the number of parameters, and the value of most parameters tends to be
unknown. Stereotypical models based on a simplified description that ignores the
details of specific systems consist of few components, few kinetic rate constants and
avoid the artifacts that might emerge from complex, parameter-rich models. Models of
HIV infections developed upon the above principles have pioneered the field [1,2].
Nevertheless, models tracking a larger number of immune components are often desir-
able when studying the progression of an infection or disease.
Given our need to study the dynamics of immune responses to infection across dif-
ferent biological scales, and the limitations posed by the current state of empirical
data, here we discuss the applications of simple versus complex models, and explore
the use of discrete dynamic models. Excellent reviews of mathematical modeling in
Table 1 Overview of dynamic modeling methods
Dynamic modeling
method
Granularity Examples in
immunology
Pros and cons Refs.
Discrete dynamic
models
Discrete time and
discrete (abstract)
state
Modeling of Bordetella
infection pathogenesis, T
cell receptor signaling
Can deal with many
components but the simple
state description cannot
replicate continuous
variation of immune
components.
[6,44-47]
Continuous-discrete
hybrid models (e.g.
piecewise linear
differential
equations)
Combination of
discrete and
continuous state,
continuous time
Modeling of infection
pathogenesis and
pathogen time-courses
The number of components
that can be modeled is
smaller than in discrete
models because of the
increase in the number of
parameters. The state of the
variables may not be
directly comparable with
experimental measurements.
Although there are few
parameters per component,
parameter estimation
becomes an issue for large
systems.
[7,36]
Differential
equations
Continuous time
and state
SIR (Susceptible Infectious
and Recovered) models
of target cells and
pathogens, T cell
differentiation
The variables of the model
can reproduce the
experimentally observed
concentrations. Insufficient
data to inform the
functional forms and
parameter values can limit
the use of this method. Less
scalable than discrete
approaches.
[11,13,20]
Finite state
automata (e.g.
agent-based
models)
Discrete states
(abstraction of cell
state), discrete
space and
continuous time
Cell to cell
communications
Simplified way to simulate
spatial aspects. Can handle a
few immune components in
detail. Computationally
expensive.
[48-50]
Partial differential
equations
Continuous time,
state and space
Transport of cells across
vascular membranes
Appropriate to model a few
immune components in
detail. Computationally
expensive and the
determination of parameters
is rather difficult.
[51,52]
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Discussion
Models of sub-systems or simplified immune response
Models can be kept relatively simple by detailing a few chosen processes and abstract-
ing others. The number of components th a tn e e dt ob ei n c l u d e di nt h em o d e li s
reduced by focusing on a sub-system such as T cell expansion or the innate immune
response, or by abstracting the immune response.
Dynamic models focusing on sub-systems of the immune response can be used to
estimate specific parameters when appropriate empirical data is available. For example,
mathematical models of T cell dynamics can be used to estimate T cell decay, produc-
tion rates [11], killing rates [12], and the fate of recently produced T cells [13]. Such
parameter estimates assist in the estimation of the in vivo basic reproduction number
(R0) of viral infections. They are also useful for studying the efficacy of treatment for
viral infections such as HIV [14,15]. Models revealing the differences in T cell
dynamics of mice and humans [16] are critical in extending the empirical observations
from mice to humans. Models tracking the dynamics of virus infection of host cells
and cellular innate response, for example type I Interferon, predict the rates of target
cell depletion in equine influenza virus infections [17].
Several dynamic models that simplify the immune response characterize the patho-
gen behavior in detail. Thus they can be used to determine the optimal conditions for
within-host survival of a pathogen. For instance, the limited availability of red blood
cells (resource limitation) can explain the early dynamics of malaria [4]. Similar models
also reveal the pathogen-induced constraints leading to acute or persistent infections
[18]. Although these models are based on assumptions such as correlation between
v i r u l e n c ea n dg r o w t hr a t eo ft h ep a t h o g e n[ 1 8 , 1 9 ] ,t h e yg i v ei m p o r t a n ti n s i g h ti n t o
pathogenesis.
Models of infection pathogenesis
The complexity of the models increases when they aim to capture multiple compo-
nents of the immune response, which can include interactions between pathogen and
host factors and the subsequent generation of specific antibody and T cell responses.
The choice of mathematical description is critical in such instances due to the intrica-
cies it can add or simplify. One example is a quantitative model constructed to simu-
late the immune response to infections by Mycobacterium tuberculosis (Mtb) [20,21]
that tracks the dynamics of resident macrophages, immature dendritic cells, infected
macrophages and mature dendritic cells. The dynamic causality in this model is
approximated by mass-action and Michaelis-Menten kinetics. Since there are quantita-
tive estimates available for Mtb (see table 4 in [20,21]), the model can parameterize
the continuous change of immune components as a function of time. The model
reveals specific parameters defining the dynamics of the host’s immune processes that
are important in persistent and acute infections. The simulated dynamics are validated
by nonhuman primate data consisting of necropsies of Mtb infected animals [22].
In the absence of quantitative and mechanistic information, but having assembled a
causal interaction network of the intra-cellular and cellular players elucidated by
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a few parameters can be followed. This discrete dynamic approach is supported by the
observations that regulatory networks maintain their function even when faced with
fluctuations in components and reaction rates [23-31]. Various discrete dynamic
frameworks including Boolean networks [32], finite dynamical systems [33], difference
equations [34], and Petri nets [35] have been used in modeling biological systems.
Particularly, Boolean network models assume that each component has two qualitative
states (e.g. active and inactive) and reproduce a sequence of switching events instead
of modeling exact time courses. The active qualitative state can be interpreted as the
concentration of an immune component that can induce downstream signaling. Such
network models, tracking the dynamics of more than 30 immune components includ-
ing various cytokines and cells, have been constructed for two Bordetella pathogens
[6,7], for which few quantitative parameters have been determined. These models
reproduce the qualitative features, such as the number of peaks, of the experimental
time-courses of various immune components such as neutrophils and dominant
cytokines.
Continuous-discrete hybrid models [7,36,37] are also developed with the aim to
improve the representation of time while retaining the simplicity of switching func-
tions. These hybrid models have a relatively small number of parameters, such as acti-
vation thresholds and decay rates, which are at a higher, more coarse-grained level
than the kinetics of elementary reactions. A hybrid Bordetella model [7] reveals that
many parameter combinations are compatible with the existing experimental knowl-
edge on the pathogenesis. The distribution of the parameter values for each immune
component in the model tells us about its role in the pathogenesis. Recent experimen-
tal measurements validate the IL4 time-course predicted by the model [Pathak, A. K.,
Creppage, K. E., Werner, J. R., Cattadori, I. M., “Immune regulation of a chronic bac-
terial infection and consequences for pathogen transmission”, submitted].
Since the immune responses involve interactions at the site of infection, the matura-
tion of T and B cells in the lymph nodes and the transport of cells through blood, cap-
turing spatial dynamics may be critical for the success of a model. Approximations at
various levels of detail are available that allow for the inclusion of some spatial infor-
mation in the form of spatial compartments, coarse grids or reaction-diffusion pro-
cesses. For example, the follow-up models of Mtb and Bordetellae [7,20] define two
compartments, the site of infection (the lung) and the site of T cell differentiation
(lymph node). A more detailed approach used by Gammack et. al. [38,39] describes
granuloma formation in Mtb infections with a reaction-diffusion model using partial
differential equations and the movement of innate immune cells toward a focal point
of Mtb infection with a coarse-grid spatial formulation.
Pros and cons of qualitative and quantitative approaches
The decision to use qualitative or quantitative models is based on the density of obser-
vations over time, the number of molecular or cellular players participating in a parti-
cular process and the connectivity of the regulatory network formed by these players.
We note that both approaches necessitate knowledge of the causal or interaction
network among components. Missing data and within-lab variations caused by the use
of different experimental systems can introduce uncertainty in the determination of
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[40]. Observations taken at many time-points minimize the uncertainty about the
behavior between the observations. The availability of frequent measurements for all or
almost all the immune components one wants to model facilitates the use of quantita-
tive modeling. The unavailability of such data guides us to use qualitative models
which will inform us about the sequence of events and ultimate outcomes rather than
trying to interpolate between the existing sparse observations. The assumption of
switch-like regulatory relationships underlying qualitative models is a good approxima-
tion if the functional form of the regulatory relationship is sigmoidal.
Qualitative and quantitative approaches detail the immune interactions at different
levels. Generally speaking, quantitative models give a detailed description of a relatively
small number of interactions whereas qualitative models incorporate more interactions
but have fewer kinetic details. Quantitative models offer predictions of kinetic para-
meters and of how the system will behave at a given instance. Qualitative models pre-
dict the response to knock-out or over-expression of components. An effective strategy
to bridge these two approaches can be to iteratively refine qualitative models as more
quantitative information becomes available through incorporation of more states, using
a continuous-discrete hybrid formalism, or a fully quantitative description of an impor-
tant sub-system.
Quantitative models require substantial prior knowledge and the interactions that
require parameterization in these models have not yet been quantitatively characterized
for most of the infections. The assumptions and estimations necessary to give values
for the parameters may introduce unwanted artifacts in the model, reducing its useful-
ness. Since many molecular and cellular players of the immune cascades [41,42] are
available for a range of infectious diseases, along with the outcomes of pathogen
manipulation experiments, qualitative models can be constructed for less studied infec-
tious diseases giving us insight about the dynamic interplay arising from the complex
multi-scale interactions. Qualitative models also lose their simplicity and usefulness if
the number of components and interactions included in the network is too large since
that dramatically increases the system’s dynamic repertoire. Various network simplifi-
cation methods are available which reduce the number of components, for instance
based on shortening long linear paths or collapsing alternative paths between a pair of
nodes [43].
Conclusion
The simple models developed to study parts of the immune system decipher para-
meters that reveal the regulation of immune responses and allow us to extrapolate the
observations from experimental hosts to the natural hosts. The models developed to
test the evolutionary fitness of pathogens reveal fundamental characteristics of the
host-pathogen interactions and give useful insight into the pathogenesis of the infec-
tions. Among the models which aim to describe most of the immune components
important in the pathogenesis, we show that both qualitative and quantitative models
can be used effectively to study the progression of the infections.
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